{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:23:37Z","timestamp":1790882617157,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Intra-tumoural administration of tigilanol tiglate has been shown effective in local treatment of cutaneous equine neoplasias. The drug causes rapid oncolysis and tumour slough, but may also be associated with comorbidities in sensitive and\/or intricate anatomical sites due to its initial pro-inflammatory mode of action. Here we describe two approaches to optimise and further de-risk treatment of equine sarcoids with tigilanol tiglate, especially in difficult locations. Firstly, we provide preliminary clinical and observational data on the efficacy of low dose administration of tigilanol tiglate (metronomic or single intra-tumoural administration). Secondly, we provide proof of therapeutic concept for tigilanol tiglate eluting calcium sulphate beads by evaluating elution characteristics and assessing clinical efficacy treating equine sarcoids. Clinical efficacy, at substantially lower than previously reported tigilanol tiglate treatment doses, was demonstrated by adopting either a single low-dose or metronomic dosing schedule or an eluting implant. Treatments resulted in complete tumour slough in all instances while evoking a perceived reduction in inflammatory responses compared to the use of previously established higher doses for equine sarcoids. While implanted calcium sulphate beads loaded with cytostatic drugs have been used previously for local treatment of equine neoplasia, their utility for local delivery of tigilanol tiglate has not been explored before. Elution analysis of tigilanol tiglate from 5 and 2.5\u202fmm loaded calcium sulphate beads showed beads eluted ~40% and ~24% of their tigilanol tiglate content in horse serum (HS) with continued release observed from intact beads for at least 4\u202fdays. The ease of implanting absorbable tigilanol tiglate loaded calcium sulphate beads, and its clinical efficacy in sarcoid treatment, showed the potential of this approach to eliminate common challenges associated with intra-tumoural injection such as inadvertent diffusion from injection sites or the difficulty injecting fibrous tumours. This contributed to reducing the apparent extent of local inflammatory responses and limiting possible associated morbidities. Apart from mild leukotrichia that developed at some treatment sites, healing and cosmetic outcome was deemed excellent. Ongoing studies evaluating the clinical efficacy and safety of lowered tigilanol tiglate doses in a statistically relevant, representative equine population are required to further develop the reported treatment regimens.<\/jats:p>","DOI":"10.3389\/fvets.2026.1807796","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:52:30Z","timestamp":1787921550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Proof of concept for low dose and delayed release of tigilanol tiglate in the treatment of equine sarcoids"],"prefix":"10.3389","volume":"13","author":[{"given":"Gideon P.","family":"Stemmet","sequence":"first","affiliation":[{"name":"School of Animal and Veterinary Science, Faculty of Science, Charles Sturt University","place":["Wagga Wagga, NSW, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Parsons","sequence":"additional","affiliation":[{"name":"QIMR Berghofer Medical Research Institute","place":["Hertson, QLD, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Johns","sequence":"additional","affiliation":[{"name":"QIMR Berghofer Medical Research Institute","place":["Hertson, QLD, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Reddell","sequence":"additional","affiliation":[{"name":"QBiotics Group Ltd.","place":["Yungabarra, QLD, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Labens","sequence":"additional","affiliation":[{"name":"School of Animal and Veterinary Science, Faculty of Science, Charles Sturt University","place":["Wagga Wagga, NSW, Australia"]},{"name":"QBiotics Group Ltd.","place":["Yungabarra, QLD, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fvets.2020.00639","article-title":"Use of the intratumoural anticancer drug tigilanol tiglate in two horses","volume":"7","author":"De Ridder","year":"2020","journal-title":"Front Vet Sci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/evj.14502","article-title":"Intratumoural tigilanol tiglate in the multicentre treatment of equine sarcoids and cutaneous melanomas","volume":"58","author":"Labens","year":"2025","journal-title":"Equine Vet J"},{"key":"ref3","author":"Melo","year":"2019"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"675804","DOI":"10.3389\/fvets.2021.675804","article-title":"Intratumoural treatment of 18 cytologically diagnosed canine high-grade mast cell tumours with Tigilanol Tiglate","volume":"8","author":"Brown","year":"2021","journal-title":"Front Vet Sci"},{"key":"ref5","first-page":"496","article-title":"Use of tigilanol tiglate in therapy of equine skin tumors","volume":"74","author":"Jehlicka","year":"2024","journal-title":"Veterinarstvi"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"105926","DOI":"10.1016\/j.tvjl.2022.105926","article-title":"Management of equine sarcoids","volume":"291","author":"Hollis","year":"2023","journal-title":"Vet J"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cveq.2024.07.006","article-title":"What is the evidence behind sarcoid treatments?","volume":"40","author":"Hollis","year":"2024","journal-title":"Vet Clin North Am Equine Pract"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cveq.2024.07.007","article-title":"Squamous cell carcinomas in horses: an update of the aetiopathogenesis and treatment options","volume":"40","author":"Hollis","year":"2024","journal-title":"Vet Clin North Am Equine Pract"},{"key":"ref9","first-page":"1298","article-title":"The use of tigilanol tiglate in two horses with mastcell tumors","volume":"102","author":"Graner","year":"2021","journal-title":"Prakt Tierarzt"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"O1","DOI":"10.1111\/vsu.14127","article-title":"Scientific presentation abstracts","volume":"53","author":"Noordwijk","year":"2024","journal-title":"Vet Surg"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4103\/0976-500X.136098","article-title":"Metronomic chemotherapy","volume":"5","author":"Maiti","year":"2014","journal-title":"J Pharmacol Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fvets.2024.1397376","article-title":"Metronomic chemotherapy: bridging theory to clinical application in canine and feline oncology","volume":"11","author":"Petrucci","year":"2024","journal-title":"Front Vet Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1053\/j.jfas.2009.05.001","article-title":"The in vitro elution characteristics of vancomycin from calcium phosphate\u2013calcium sulfate beads","volume":"48","author":"Scharer","year":"2009","journal-title":"J Foot Ankle Surg"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.msec.2017.03.164","article-title":"Co-delivery of cisplatin and doxorubicin from calcium phosphate beads\/matrix scaffolds for osteosarcoma therapy","volume":"77","author":"Hess","year":"2017","journal-title":"Mater Sci Eng C"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/jbm.b.31269","article-title":"Calcium sulfate: properties and clinical applications","author":"Thomas","year":"2009","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3390\/coatings12091350","article-title":"Calcium sulfate in implantology (biphasic calcium sul-fate\/hydroxyapatite, BCS\/HA, bond apatite): review of the literature and case reports","volume":"12","author":"Torrejon-Moya","year":"2022","journal-title":"Coatings"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/jbm.b.20012","article-title":"Bone-defect healing with calcium-sulfate particles and cement: an experimental study in rabbit","author":"Orsini","year":"2004","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2460\/ajvr.22.12.0216","article-title":"Bead size has a greater effect on in vitro elution from antimicrobial-impregnated calcium sulfate beads than drug concentration","volume":"84","author":"Olsen","year":"2023","journal-title":"Am J Vet Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1111\/eve.13662","article-title":"Evaluation of a subcutaneously implanted biodegradable matrix with and without cisplatin in horses","volume":"35","author":"Marble","year":"2023","journal-title":"Equine Vet Educ"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.2460\/ajvr.77.11.1252","article-title":"Elution of platinum from carboplatin-impregnated calcium sulfate hemihydrate beads in vitro","volume":"77","author":"Tulipan","year":"2016","journal-title":"Am J Vet Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/vsu.13511","article-title":"Repeatability of in vitro carboplatin elution from carboplatin-impregnated calcium sulfate hemihydrate beads made in a clinic setting","volume":"49","author":"Worth","year":"2020","journal-title":"Vet Surg"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0241718","DOI":"10.1371\/journal.pone.0241718","article-title":"Evaluation of bioabsorbable calcium sulfate hemihydrate beads for local delivery of carboplatin","volume":"15","author":"Traverson","year":"2020","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1053\/j.ctep.2005.10.008","article-title":"A suggested clinical classification for the equine sarcoid","volume":"4","author":"Knottenbelt","year":"2005","journal-title":"Clin Tech Equine Pract"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/0300985820985114","article-title":"Equine sarcoids\u2014causes, molecular changes, and clinicopathologic features: a review","volume":"58","author":"Og\u0142uszka","year":"2021","journal-title":"Vet Pathol"},{"key":"ref25","first-page":"1103","article-title":"Epidemiology of equine sarcoids in horses in western Canada","volume":"51","author":"Wobeser","year":"2010","journal-title":"Can Vet J"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.tvjl.2018.08.009","article-title":"The clinical diagnosis of equine sarcoids \u2014 part 1: assessment of sensitivity and specificity using a multicentre case-based online examination","volume":"242","author":"Koch","year":"2018","journal-title":"Vet J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1463-5224.2000.00119.x","article-title":"The diagnosis and treatment of periorbital sarcoid in the horse: 445 cases from 1974 to 1999","volume":"3","author":"Knottenbelt","year":"2000","journal-title":"Vet Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cveq.2017.08.004","article-title":"Periocular neoplasia in the horse","volume":"33","author":"Estell","year":"2017","journal-title":"Vet Clin North Am Equine Pract"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.5114\/pjr.2020.96156","article-title":"Gross tumour volume comparison in oropharynx carcinomas using different intelligent imaging software. A retrospective analysis","volume":"85","author":"Stuppner","year":"2020","journal-title":"Pol J Radiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2008.03.009","article-title":"Techniques for intratumoral chemotherapy of lung cancer by bronchoscopic drug delivery","volume":"61","author":"Celikoglu","year":"2008","journal-title":"Cancer Therapy"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jso.2930310402","article-title":"Tumor measurement in the nude mouse","volume":"31","author":"Euhus","year":"1986","journal-title":"J Surg Oncol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cveq.2013.09.002","article-title":"Sarcoids","volume":"29","author":"Bergvall","year":"2013","journal-title":"Vet Clin: Equine Practice"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/evj.12421","article-title":"A database survey of equine tumours in the U nited K ingdom","volume":"48","author":"Knowles","year":"2016","journal-title":"Equine Vet J"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/104063870601800121","article-title":"Survey of equine cutaneous neoplasia in the Pacific northwest","volume":"18","author":"Valentine","year":"2006","journal-title":"J Vet Diagn Invest"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e108887","DOI":"10.1371\/journal.pone.0108887","article-title":"Intra-lesional injection of the novel PKC activator EBC-46 rapidly ablates tumors in mouse models","volume":"9","author":"Boyle","year":"2014","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3390\/vaccines11040769","article-title":"Immunotherapy of equine sarcoids\u2014from early approaches to innovative vaccines","volume":"11","author":"Jindra","year":"2023","journal-title":"Vaccine"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12917-017-1215-0","article-title":"Topical use of 5% acyclovir cream for the treatment of occult and verrucous equine sarcoids: a double-blinded placebo-controlled study","volume":"13","author":"Haspeslagh","year":"2017","journal-title":"BMC Vet Res"},{"key":"ref38","first-page":"2209","article-title":"Modeling multi-needle injection into solid tumor","volume":"9","author":"Subbotin","year":"2019","journal-title":"Am J Cancer Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2460\/javma.229.10.1617","article-title":"Use of cisplatin-containing biodegradable beads for treatment of cutaneous neoplasia in equidae: 59 cases (2000\u20132004)","volume":"229","author":"Hewes","year":"2006","journal-title":"J Am Vet Med Assoc"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10637-018-0604-y","article-title":"Optimising intratumoral treatment of head and neck squamous cell carcinoma models with the diterpene ester Tigilanol tiglate","volume":"37","author":"Barnett","year":"2019","journal-title":"Investig New Drugs"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/jvim.15806","article-title":"Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate (EBC-46)","volume":"35","author":"De Ridder","year":"2021","journal-title":"J Vet Intern Med"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-3164.2006.00526.x","article-title":"Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: a pilot study","volume":"17","author":"Nogueira","year":"2006","journal-title":"Vet Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.3928\/01477447-20130122-25","article-title":"Use of a calcium sulfate-calcium phosphate synthetic bone graft composite in the surgical management of primary bone tumors","volume":"36","author":"Evaniew","year":"2013","journal-title":"Orthopedics"},{"key":"ref44","first-page":"211","volume-title":"Absorbable bone substitute materials based on calcium Sulfate as triggers for Osteoinduction and Osteoconduction","author":"Pf\u00f6rringer","year":"2019"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1902\/jop.2000.71.6.940","article-title":"Prospective study on the augmentation of the maxillary sinus with calcium Sulfate: histological results","volume":"71","author":"De Leonardis","year":"2000","journal-title":"J Periodontol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2241326","DOI":"10.1080\/20002297.2023.2241326","article-title":"Defining in vitro topical antimicrobial and antibiofilm activity of epoxy-tigliane structures against oral pathogens","volume":"15","author":"Xue","year":"2023","journal-title":"J Oral Microbiol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12891-022-05230-y","article-title":"Antibiotic-loaded calcium sulfate beads in spinal surgery for patients with spondylodiscitis: a clinical retrospective study","volume":"23","author":"Tang","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"eabn3758","DOI":"10.1126\/scitranslmed.abn3758","article-title":"Topical, immunomodulatory epoxy-tiglianes induce biofilm disruption and healing in acute and chronic skin wounds","volume":"14","author":"Powell","year":"2022","journal-title":"Sci Transl Med"},{"key":"ref49","first-page":"519","article-title":"PP059 EBC-1013 induces an acute inflammatory response in skin relevant cell types, promoting innate immune cell recruitment and subsequent closure of chronic, infected wounds","volume":"24","author":"Cullen","year":"2023","journal-title":"J Wound Manag"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e02314\u201325","DOI":"10.1128\/mbio.02314-25","article-title":"Epoxytiglianes potentiate the activity of colistin against resistant Escherichia coli via modification of the bacterial cell membrane","volume":"17","author":"Pritchard","year":"2025","journal-title":"MBio"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1807796\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:52:31Z","timestamp":1787921551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1807796\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":50,"alternative-id":["10.3389\/fvets.2026.1807796"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2026.1807796","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"article-number":"1807796"}}